aspen aerogels inc - ASPN

ASPN

Close Chg Chg %
3.47 0.23 6.49%

Closed Market

3.69

+0.23 (6.49%)

Volume: 1.38M

Last Updated:

Apr 2, 2026, 3:59 PM EDT

Company Overview: aspen aerogels inc - ASPN

ASPN Key Data

Open

$3.35

Day Range

3.32 - 3.73

52 Week Range

2.30 - 9.76

Market Cap

$305.63M

Shares Outstanding

82.83M

Public Float

69.19M

Beta

2.90

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$4.74

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.33M

 

ASPN Performance

1 Week
 
11.82%
 
1 Month
 
14.60%
 
3 Months
 
27.68%
 
1 Year
 
-32.54%
 
5 Years
 
-82.25%
 

ASPN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

About aspen aerogels inc - ASPN

Aspen Aerogels, Inc. engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. It operates through the following segments: Thermal Barrier and Energy Industrial. The Thermal Barrier segment is actively developing aerogel products and technologies for the EV market. The Energy Industrial segment designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in the energy industrial and sustainable insulation markets. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee on May 4, 2001 and is headquartered in Northborough, MA.

ASPN At a Glance

Aspen Aerogels, Inc.
30 Forbes Road
Northborough, Massachusetts 01532
Phone 1-508-691-1111 Revenue 271.10M
Industry Industrial Specialties Net Income -389,552,000.00
Sector Process Industries Employees 854
Fiscal Year-end 12 / 2026
View SEC Filings

ASPN Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.859
Price to Book Ratio 0.994
Price to Cash Flow Ratio 7.09
Enterprise Value to EBITDA -99.103
Enterprise Value to Sales 0.805
Total Debt to Enterprise Value 0.659

ASPN Efficiency

Revenue/Employee 317,450.82
Income Per Employee -456,149.883
Receivables Turnover 7.687
Total Asset Turnover 0.416

ASPN Liquidity

Current Ratio 3.902
Quick Ratio 3.285
Cash Ratio 2.557

ASPN Profitability

Gross Margin 16.967
Operating Margin -18.772
Pretax Margin -142.808
Net Margin -143.692
Return on Assets -59.847
Return on Equity -91.635
Return on Total Capital -102.723
Return on Invested Capital -68.966

ASPN Capital Structure

Total Debt to Total Equity 61.017
Total Debt to Total Capital 37.895
Total Debt to Total Assets 35.337
Long-Term Debt to Equity 46.339
Long-Term Debt to Total Capital 28.779
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Aspen Aerogels Inc - ASPN

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
180.36M 238.72M 452.70M 271.10M
Sales Growth
+48.30% +32.35% +89.64% -40.11%
Cost of Goods Sold (COGS) incl D&A
175.39M 181.80M 265.70M 225.10M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
11.86M 18.18M 24.41M 48.69M
Depreciation
11.86M 18.18M 24.41M 48.69M
Amortization of Intangibles
- - - -
-
COGS Growth
+57.04% +3.65% +46.15% -15.28%
Gross Income
4.98M 56.92M 187.00M 46.00M
Gross Income Growth
-49.92% +1,043.91% +228.52% -75.40%
Gross Profit Margin
+2.76% +23.84% +41.31% +16.97%
2022 2023 2024 2025 5-year trend
SG&A Expense
84.22M 106.12M 122.05M 96.89M
Research & Development
16.93M 16.36M 18.05M 13.42M
Other SG&A
67.29M 89.77M 104.00M 83.47M
SGA Growth
+66.66% +26.01% +15.01% -20.62%
Other Operating Expense
- - - -
-
Unusual Expense
- - 35.10M 306.89M
-
EBIT after Unusual Expense
(79.25M) (49.20M) 29.85M (357.78M)
Non Operating Income/Expense
1.62M 8.72M (2.80M) (18.66M)
Non-Operating Interest Income
- - 1.62M 6.53M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
5.11M 5.33M 11.96M 10.72M
Interest Expense Growth
+2,131.44% +4.27% +124.46% -10.39%
Gross Interest Expense
5.11M 5.33M 11.96M 10.72M
Interest Capitalized
- - - -
-
Pretax Income
(82.74M) (45.81M) 15.09M (387.16M)
Pretax Income Growth
-123.05% +44.63% +132.94% -2,665.83%
Pretax Margin
-45.87% -19.19% +3.33% -142.81%
Income Tax
- - 1.71M 2.39M
-
Income Tax - Current - Domestic
- - - 323.00K
-
Income Tax - Current - Foreign
- - - 2.49M
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - (416.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(82.74M) (45.81M) 13.38M (389.55M)
Minority Interest Expense
- - - -
-
Net Income
(82.74M) (45.81M) 13.38M (389.55M)
Net Income Growth
-123.05% +44.63% +129.20% -3,012.54%
Net Margin Growth
-45.87% -19.19% +2.95% -143.69%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(82.74M) (45.81M) 13.38M (389.55M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(82.74M) (45.81M) 13.38M (389.55M)
EPS (Basic)
-2.1019 -0.6597 0.1725 -4.7317
EPS (Basic) Growth
-72.44% +68.61% +126.15% -2,843.01%
Basic Shares Outstanding
39.36M 69.44M 77.54M 82.33M
EPS (Diluted)
-2.1019 -0.6597 0.1666 -4.7317
EPS (Diluted) Growth
-72.44% +68.61% +125.25% -2,940.16%
Diluted Shares Outstanding
39.36M 69.44M 80.31M 82.33M
EBITDA
(67.38M) (31.03M) 89.36M (2.20M)
EBITDA Growth
-128.10% +53.96% +388.01% -102.46%
EBITDA Margin
-37.36% -13.00% +19.74% -0.81%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 4.50
Number of Ratings 6 Current Quarters Estimate -0.213
FY Report Date 06 / 2026 Current Year's Estimate -0.753
Last Quarter’s Earnings -0.27 Median PE on CY Estimate N/A
Year Ago Earnings -4.73 Next Fiscal Year Estimate -0.155
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 4 4
Mean Estimate -0.21 -0.15 -0.75 -0.16
High Estimates -0.19 -0.11 -0.68 -0.07
Low Estimate -0.23 -0.19 -0.86 -0.26
Coefficient of Variance -8.04 -21.67 -10.14 -53.85

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 5
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Aspen Aerogels Inc in the News